Donald J. Avison
Don Avison is a lawyer and consultant with the Avison and Associates in Victoria, British Columbia. Prior to returning to private practice, he had a long and distinguished career in the public sector. With the federal Department of Justice, he served in many roles including general counsel, regional director general and as the first director general responsible for the Aboriginal Justice Initiative. This was followed by an appointment as deputy minister of justice for the Northwest Territories. He then returned home to BC, where he held the deputy minister appointments in Education, Advanced Education, Crown Corporations and Health. He left government in 1999 and spent the next 10 years providing leadership as the first president of the University Presidents’ Council (now the Research Universities Council) of BC. Don served on the Providence Health Care Board from 2010-2013 and joined the Board of the Centre for Drug Research and Development in February of 2014.
With more than 20 years of senior management experience, including previous positions as the Provincial Health Services Authority (PHSA) Chief Communications Officer and VP Communications & Research Administration, Ellen Chesney brings a strong background in health care and strategic management to her current position as Chief Administrative Officer, Research for the PHSA.
As Chief Administrative Officer, Research, Ms. Chesney works with PHSA agencies and research institutes to maximize opportunities for efficiencies and effectiveness in research administration. She also works in collaboration with senior health care and academic leaders to strengthen and advance PHSA’s role as an academic health care organization. Prior to joining the PHSA, Ms. Chesney was the Director of Public Affairs and Communications with Children’s & Women’s Health Centre of BC.
Ms. Chesney holds an Executive MBA from the UBC Sauder School of Business, and a Bachelor of Journalism, High Honours, from Carleton University, and is a graduate of the Queen’s Executive Development Program. She has served as a director on the board of a variety of research institutes, professional associations and non-profit societies. Ellen joined the Foundation’s Board on November 17, 2009, was appointed Secretary in July 2012, Secretary-Treasurer in October 2013, and then Secretary again in April 2016.
Carmond joined the board on April 11, 2016, as a Director and Treasurer. He is a consultant specializing in strategy, finance and accounting. Carmond obtained his Chartered Professional Accountant designation through PwC Vancouver, providing assurance advisory services for private and public companies in financial services, technology and life sciences sectors. Carmond has work experience in healthcare through Johnson & Johnson as a Financial Analyst and Providence Health Care as a Clinical Research Assistant & Laboratory Technician for the British Columbia Centre for Excellence in HIV/AIDS. His work within precision medicine diagnostics for HIV and HCV patients have been co-authored into several peer-reviewed journals.
Carmond holds an Honours Bachelor of Science from McMaster University, Diploma in Accounting from the UBC Sauder School of Business, Masters in Professional Accounting from the Edwards School of Business and a Masters in Business Administration (MBA) with a concurrent Graduate Diploma in Health Industry Management from the Schulich School of Business.
Andrew Hazlewood is the former Assistant Deputy Minister of Population Health and Wellness for the British Columbia Ministry of Health Planning. Mr. Hazlewood began his career in Public Health in 1972 with the Saskatchewan Department of Health. In 1986, he joined the British Columbia Ministry of Health and has held increasingly responsible positions in the public and preventive health field. He was responsible for developing policy frameworks for all health prevention, promotion and protection programs, including specific strategic initiatives targeted towards Women’s and Seniors health issues, Aboriginal Health, HIV/AIDS and Tobacco Issues. Mr. Hazlewood provided direction and leadership on all aspects of British Columbia’s tobacco reduction strategy.
Cathy Daminato is recognized as an innovative, energetic and strategic executive with the ability to motivate and inspire extraordinary commitment and support in aid of health and education initiatives in Greater Vancouver. Over the past 28 years, Cathy has held leadership roles at Douglas College, BCIT, the Royal Columbian Hospital Foundation.
In 2003, she became the first Vice-President of Advancement and Alumni Engagement at Simon Fraser University, tripling the fundraising activity, building endowments and raising significant funds for key capital projects. Most recently under Cathy’s leadership SFU launched and successfully completed its largest fundraising effort to date, the $250 million Power and Engagement 50th Anniversary Campaign, raising $275 million. Cathy’s leadership ability, authenticity, strategic thinking, marketing acumen and communications skills have been critical to her success. As a volunteer she led the creation of a new fundraising management certificate program at BCIT, and served on various boards and committees of the Association of Fundraising Professionals nationally and internationally, including a term as Chair of the Association of Fundraising Professionals Vancouver Chapter. She has also been a board member of the Canadian Council for the Advancement of Education, the SFU University Trust, President of the SFU Foundation and Friends of SFU Foundation, and a member of BC Pets and Friends.
Cathy was awarded the AFT’s Giving Hearts Lifetime Achievement Award in November 2014 and was a finalist for a Woman of Distinction Award in the Non-profit and Public Service category in 2007.
Cathy holds a B.Sc. (Life Sciences with Honours) from Queen’s University, and MBA from the University of British Columbia and an ICD.D designation by the Institute of Corporate Directors in Toronto, Ontario.
Judith G. Hall
Dr. Judith Hall, Professor Emerita in the Departments of Pediatrics and Medical Genetics, is a pediatrician and clinical geneticist who has worked on birth defects and non-traditional mechanisms of disease. She has published over 350 original articles, 150 chapters and sections of conference proceedings, and 10 books, 2 of which have received awards. She has conducted clinical research for the past 40 years with a major interest in the description of the natural history of genetic disorders, congenital anomalies, and arthrogryposis. She has served in many leadership roles, including Chair of the UBC and BC Children’s Hospital Departments of Pediatrics, as well as on numerous national and international committees and boards. She has served as president of the Western Society of Pediatrics, American Society of Human Genetics and of the American Pediatric Society. Dr. Hall was a Board member of Genome Canada, the Michael Smith Foundation for Health Research, the Science Advisory Board of Health Canada, the Vancouver Foundation, and the Canadian Institute of Academic Medicine.
Dr. Hall has received Lifetime Achievement Awards from Wellesley College, the University of Washington Medical School, and the University of British Columbia Medical School. Dr. Hall was named one of America’s top 1,000 doctors by American Health magazine and she became an Officer of the Order of Canada in 1998, Founding Fellow of the Canadian Academy of Health Sciences in 2005, and a Fellow of the Royal Society of Canada in 2011. Dr. Hall received the Queen Elizabeth II Diamond Jubilee Medal in 2014, was inducted to The Canadian Medical Hall of Fame in 2015, received a Lifetime Achievement Award from the American College of Medical Genetics and an Honorary Degree from UBC in 2018.
Kelly is a partner in Human Capital Strategies, a consulting firm specializing in workforce development. She is a senior executive with over 20 years’ experience leading not-for-profit organizations.
Prior to HCS, Kelly founded and led the Immigrant Employment Council of BC as its CEO. IEC-BC is the provincial employer-facing organization that achieves the integration of skilled immigrant talent into the province’s workforce.
Kelly brings more than 20 years of experience in developing strategic initiatives to attract and integrate internationally trained talent in BC. She is a sought-after speaker, and a thought-leader and subject matter expert on immigration.
Prior to IEC-BC, Kelly was the Director of Employment and Language Programs at MOSAIC, one of the largest immigrant serving organizations in Western Canada.
Born in the United Kingdom in 1943, Dr. Perry Kendall completed his undergraduate medical training at University College Hospital Medical School in 1968 and interned at the Seaman’s Hospital in Greenwich, before spending a year as Senior House Officer at the University Hospital of the West Indies in Kingston, Jamaica. In 1972, he moved to Toronto, Ontario and spent two years working in general practice and at Toronto’s Hassle Free Clinic.
In 1974, he moved to Vancouver and worked for the Vancouver Health Department’s Pine Free Clinic and East Health unit while acquiring a Master’s Degree in Health Care Planning and Epidemiology and a Fellowship in Community Medicine. In 1984, he returned to Ontario and was the Manager, Disease Control and Epidemiology Services with the Ontario Ministry of Health, until 1987. He then returned to BC as Medical Officer of Health for the Capital Regional District, in which capacity he opened one of Canada’s first needle exchange programs. In 1989 he took on the role of Medical Health Officer for the City of Toronto, a position he held for six years during which time he pioneered programs for AIDS/HIV and drug abuse prevention, established Harm Reduction as the official City policy for substance abuse and was involved in developing and promoting the City’s comprehensive tobacco control by-laws.
In 1993, Dr. Kendall spent a year on secondment to the Deputy Minister of Health as Special Advisor on Long Term Care and Population Health. In March 1995, he was appointed President and CEO of the Addiction Research Foundation of Ontario, one of six academic health science centres in Toronto and a WHO Collaborating Centre, a position he held until the Foundation’s amalgamation with three other hospitals to form the Addiction and Mental Health Services Corporation on January 23, 1998. In April 1998, he took on the position of Vice-President, Seniors’ Health, with the Capital Health Region in Victoria. May 3, 1999, Dr. Kendall was appointed to the position of Provincial Health Officer for the province of British Columbia. During his term as BC’s Provincial Health Officer, Dr. Kendall received a variety of awards and recognition. In particular he was awarded the Order of BC in June 2005, in part for his work on harm reeduction, including his pivotal role in establishing North America’s first legally sanctioned supervised consumption site, Insite. He received the Queen’s Diamond Jubilee Award in June 2013 and the BC Premier’s Legacy Award in October 2015. In April 2016 he was appointed to the federal government’s Cannabis Task Force, whose recommendations shaped the subsequent Cannabis Legalization Act.
Dr. Kendall retired from public service in January 2018 and joined the Foundation board in March 2018. He presently works part time as a consultant on public health issues and policy. He can be reached at email@example.com
David Patrick is interim Executive lead for the BC Centre for Disease Control. He is also the medical epidemiology lead for antimicrobial resistance at the BCCDC and a professor in the UBC School of Population and Public Health.
Dr Patrick is an infectious disease specialist and epidemioligist with a career interest in responding to emerging infectious diseases. He has published on a range of topics included HIV epidemiology, impacts of immmunization on population health and vector-borne and zoonotic disease.
His current focus is on the broad effort to contain the threat of antimicrobial resistance in Canada and around the world. He is particularly interested in an understanding of the drivers of antibiotic utilization in the community and intervening to reduce unnecessary use. His projects include Do Bugs Need Drugs” and Antibioticwise. David joined the board as an advisor in January 2019.
Dr. Jennifer Gardy is Deputy Director, Surveillance, Data, and Epidemiology at the Bill & Melinda Gates Foundation, where she leads the Foundation’s genomics- and data-driven initiatives in the malaria portfolio.
Prior to joining BMGF, Dr. Gardy was a Senior Scientist at the BCCDC, an Associate Professor at UBC’s School of Population and Public Health, and the Canada Research Chair in Public Health Genomics. During her time at BCCDC, Dr. Gardy pioneered the use of whole genome sequencing as a tool to investigate infectious disease transmission, with a particular focus on tuberculosis. In addition to her scientific work, Dr. Gardy is an award-winning science communicator, having hosted multiple episodes of CBC Television’s The Nature of Things and authoring a children’s book about microbes.
Robert C. Brunham
Dr. Robert C. Brunham is the Head of the Vaccine Research Laboratory at the University of British Columbia Centre for Disease Control. Until 2014, he was the Executive and Scientific Director of the British Columbia Centre for Disease Control (BCCDC). Dr. Brunham is also a Professor of Medicine at UBC. He has over 350 publications and an h-index of 53, as calculated by ISI’s Web of Knowledge. He is internationally regarded as an expert on infectious diseases and well known for his research on Chlamydia, SARS and HIV.
In 2005 Dr. Brunham received the CIHR Partnership Award for exemplifying research excellence by bringing health research communities together. His belief in seeking fundamental understanding of scientific problems while maximizing their benefit to society has been characterized by a career of partnership across the broad breadth of medical biosciences including molecular biology, clinical investigation and public health studies.
In 2015, Dr Brunham was elected a Fellow of the Royal Society of Canada, which is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.
In Chlamydia research, Dr. Brunham is a world authority. He has made seminal contributions to defining the clinical features of infection in women, evaluating the impact of screening and treatment control programs, determining the underlying mechanisms of immunity, and discovering protective antigens suitable for vaccine development. He has innovatively analyzed the impact of public health efforts to control Chlamydia, deduced that the strategy is arresting the development of immunity and concluded that a vaccine will be essential to success.
Dr. Brunham is also well known for his work in elucidating the SARS genome, defining the characteristic clinical features of SARS as a clinical entity and tracing its distinctive epidemiology to underlying network transmission dynamics. As well, Dr. Brunham’s contribution to understanding HIV is significant. He collaborated in determining the major role of chancroid in concentrating accelerated HIV transmission among high-risk groups in Africa and the major role of HLA molecules in HIV resistance and susceptibility.
Dr. Brunham has been integral in establishing and developing the BCCDC Foundation and has dedicated his expertise and time to the organization for ten years, providing direction, advice and invaluable support to the Board of Directors.